Christian Schorgenhofer
Overview
Explore the profile of Christian Schorgenhofer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kienbacher C, Schorgenhofer C, Ruzicka G, Grafeneder J, Hufnagl C, Jilma B, et al.
Sci Rep
. 2025 Jan;
15(1):123.
PMID: 39747939
Allergic reactions and angioedema are important immunologic conditions in acute care settings. Prior data indicate an association between symptom severity and maximum lysis (ML) in thromboelastometry. We aimed to evaluate...
2.
Derhaschnig U, Buchtele N, Steiner M, Drucker C, Firbas C, Schorgenhofer C, et al.
Res Pract Thromb Haemost
. 2024 Sep;
8(6):102518.
PMID: 39268017
Background: Recombinant tissue plasminogen activator (rt-PA) is a thrombolytic agent and essential in emergency medical care. Given recent supply shortages, the availability of biosimilar products is an urgent medical need....
3.
Zulehner G, Seidel S, Polanz A, Schorgenhofer C, Rommer P, Merrelaar M, et al.
Sci Rep
. 2023 Nov;
13(1):20405.
PMID: 37990042
Critical illness polyneuropathy (CIP) is a frequent and underdiagnosed phenomenon among intensive care unit patients. The lipophilic nature of neuronal synapses may result in the association of low serum cholesterol...
4.
Serum neurofilament light chain as an early diagnostic biomarker for critical illness polyneuropathy
Zulehner G, Schorgenhofer C, Rommer P, Merrelaar M, Behrens S, Ponleitner M, et al.
Minerva Anestesiol
. 2023 Oct;
89(12):1099-1104.
PMID: 37851416
Background: Critical illness polyneuropathy (CIP) commonly occurs in critical care unit (CCU) patients, but timely diagnosis can be challenging. Therefore, new biomarkers, such as serum neurofilament light chain (sNfL), could...
5.
Petersson L, Schorgenhofer C, Askfors Y, Justad H, Dahl M, Andersson M
Drugs Aging
. 2023 Apr;
40(4):369-376.
PMID: 37039960
Background: Polypharmacy in older people is steadily increasing and a combination of many medicines may result in adverse effects, especially if the medicines interact pharmacodynamically. Examples are additive or synergistic...
6.
Pirabe A, Schrottmaier W, Heber S, Schmuckenschlager A, Treiber S, Pereyra D, et al.
J Infect Public Health
. 2023 Jan;
16(3):384-392.
PMID: 36702013
Age represents the major risk factor for fatal disease outcome in coronavirus disease (COVID-19) due to age-related changes in immune responses. On the one hand lymphocyte counts continuously decline with...
7.
Reindl-Schwaighofer R, Hodlmoser S, Domenig O, Krenn K, Eskandary F, Krenn S, et al.
Sci Rep
. 2022 Nov;
12(1):20117.
PMID: 36418458
SARS-CoV-2 gains cell entry via angiotensin-converting enzyme (ACE) 2, a membrane-bound enzyme of the "alternative" (alt) renin-angiotensin system (RAS). ACE2 counteracts angiotensin II by converting it to potentially protective angiotensin...
8.
Gelbenegger G, Jager U, Fillitz M, Schorgenhofer C, Sillaber C, Jilma B
Blood Adv
. 2022 Nov;
7(10):1987-1990.
PMID: 36322823
No abstract available.
9.
Ay C, Pabinger I, Kovacevic K, Gelbenegger G, Schorgenhofer C, Quehenberger P, et al.
Blood Adv
. 2022 Jun;
6(18):5467-5476.
PMID: 35772170
Type 2B von Willebrand disease (VWD) is characterized by an increased binding affinity of von Willebrand factor (VWF) to platelet glycoprotein Ib. This can lead to clearance of high-molecular-weight (HMW)...
10.
Buchtele N, Schorgenhofer C, Schwameis M, Jilma B, Schellongowski P, Herkner H, et al.
Am J Respir Crit Care Med
. 2022 Apr;
206(2):170-177.
PMID: 35426776
Prostaglandin E (alprostadil; PGE), in addition to low-dose unfractionated heparin, increases the biocompatibility of extracorporeal systems and enhances the efficacy of artificial organs without increasing bleeding risk. We investigated the...